Symptomatic improvement in diabetic neuropathy after 12 months of therapy with zenarestat, an aldose reductase inhibitor

被引：0
|
作者：
Bril, V
Ng, E
Nwe, P
Gogov, S
Ngo, ML
Skandarajah, S
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2136
引用
收藏
页码：A518 / A519
页数：2
相关论文
共 50 条
  • [41] EFFECT OF AN ALDOSE REDUCTASE INHIBITOR ON DIABETIC PERIPHERAL NEUROPATHY - PRELIMINARY-REPORT
    CULEBRAS, A
    ALIO, J
    HERRERA, JL
    LOPEZFRAILE, IP
    ARCHIVES OF NEUROLOGY, 1981, 38 (02) : 133 - 134
  • [42] CRANIAL NERVE NEUROPATHY OF DIABETIC RATS IS PREVENTED BY TOLRESTAT, AN ALDOSE REDUCTASE INHIBITOR
    NOTVEST, RR
    INSERRA, JJ
    KEIM, KL
    DIABETES, 1986, 35 : A206 - A206
  • [43] Fidarestat - SNK-860 - Treatment of diabetic neuropathy - Aldose reductase inhibitor
    不详
    DRUGS OF THE FUTURE, 2001, 26 (03) : 297 - 297
  • [44] A CONTROLLED TRIAL OF SORBINIL, AN ALDOSE REDUCTASE INHIBITOR, IN CHRONIC PAINFUL DIABETIC NEUROPATHY
    YOUNG, RJ
    EWING, DJ
    CLARKE, BF
    DIABETES, 1983, 32 (10) : 938 - 942
  • [45] An aldose reductase inhibitor ameliorates diabetic autonomic neuropathy in type 2 diabetic subjects.
    Nakamura, J
    Nakayama, M
    Hamada, Y
    Chaya, S
    Kato, K
    Kasuya, Y
    Mizubayashi, R
    Miwa, K
    Yasuda, Y
    Kamiya, H
    Hotta, N
    DIABETOLOGIA, 1999, 42 : A293 - A293
  • [46] Discovery of a Novel Benzothiadiazine-Based Selective Aldose Reductase Inhibitor as Potential Therapy for Diabetic Peripheral Neuropathy
    Jin, Ruyi
    Wang, Jin
    Li, Mingyue
    Tang, Tian
    Feng, Yidong
    Zhou, Sha
    Xie, Honglei
    Feng, Haiyu
    Guo, Jianshuang
    Fu, Ruijia
    Liu, Jiping
    Tang, Yuping
    Shi, Yajun
    Guo, Hui
    Wang, Yuwei
    Nie, Fayi
    Li, Jing
    DIABETES, 2024, 73 (03) : 497 - 510
  • [47] Dose-related effects of the aldose reductase inhibitor Zenarestat on nerve sorbitol levels, nerve conduction velocity and nerve fiber density in human diabetic neuropathy.
    Greene, D
    Arezzo, J
    Brown, M
    DIABETES, 1996, 45 : 9 - 9
  • [48] ALDOSE REDUCTASE INHIBITION WITH SORBINIL IN SYMPTOMATIC DIABETIC NEUROPATHY - A 3 MONTH CLINICAL AND NEUROPHYSIOLOGICAL STUDY
    SCHOUTEN, JA
    CLINICAL TRIALS AND META-ANALYSIS, 1993, 28 (4-5) : 203 - 214
  • [49] EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR, SORBINIL, ON EXPERIMENTAL DIABETIC NEUROPATHY AND SUGAR CATARACTS IN RATS
    ISHIKO, J
    SUZUKI, M
    OHTSUKI, I
    JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P244 - P244
  • [50] WITHDRAWAL OF THE ALDOSE REDUCTASE INHIBITOR TOLRESTAT IN PATIENTS WITH DIABETIC NEUROPATHY - EFFECT ON NERVE FUNCTION
    SANTIAGO, JV
    SONKSEN, PH
    BOULTON, AJM
    MACLEOD, A
    BEG, M
    BOCHENEK, W
    GRAEPEL, GJ
    GONEN, B
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1993, 7 (03) : 170 - 178
12345